Global Embolotherapy Market - Analysis and Forecast (2021-2027)

Industry Insights by Product (Embolic Agents [Microspheres, Embolic coils, Liquid embolic agents, Embolic plug systems, Detachable balloons], Support Devices [Microcatheters, Guidewires]), by Procedure (Transcatheter Arterial Embolization [TAE], Transarterial Radioembolization/Selective Internal Radiation Therapy [TARE/SIRT], Transarterial Chemoembolization [TACE]), by Indication (Cancer [Liver, Kidney, Others], Neurological Diseases [Cerebral aneurysm, Arteriovenous malformation and fistulas], Peripheral Vascular Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders), by End User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Others), and by Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)

Industry Overview

The global embolotherapy market was valued at USD 3,600.0 million in 2020 and is expected to grow at a CAGR of 6.8% during the forecast period (2021–2027). The market is growing significantly due to the extensive incidences of liver cancer, uterine fibroids, vascular diseases, strokes along with technological progressions being undertaken in this market. Furthermore, increasing preference pertaining to nominally invasive processes and excessive funds, grants and investments availed to key players by public-private enterprises for research are another factors that are bolstering the growth of global embolotherapy market at a significant rate.

Embolotherapy is a form of endovascular treatment that intends to obstruct abnormal blood vessels for controlling bleeding, devascularise organs, arteriovenous malformations and close fistulae. Furthermore, embolotherapy is performing crucial role in medicine domain that aims at the accomplishment of occlusion and utilises various embolic agents and minimally invasive techniques for instance coils, gelfoam, angiographic, balloons and catheters. This technique helps in treating wide range of problems and utilises varies therapies such as UFE, TACE and venous embolisation for the treatment of arthritis embolization and haemorrhoid and is further witnessing technological progressions that is contributing towards rampant growth of global embolotherapy market.

Market Segmentation

Insight by Product

On the basis of product, the global embolotherapy market is categorised into embolic agents, and support devices, wherein the embolic agents category held the larger share in the market in 2020, owing to the evolution of advanced embolic agents, such as calibrated microspheres for bland embolization, and radioactive Y-90 microspheres to treat primary or secondary liver diseases.

Embolic agents are further categorized into microspheres, embolic coils, liquid embolic agents, embolic plug systems, and detachable balloons.

Support devices category is also further segmented into microcatheters and guidewires.

Insight by Procedure

On the basis of procedure, the global embolotherapy market is categorised into TAE (transcatheter arterial embolization), TACE (transarterial chemoembolization) and TARE/SIRT (transarterial radioembolization/selective internal radiation therapy). Amongst these segments, TAE segment is anticipated to generate largest revenue throughout the estimated period as transarterial embolization is used for treating kidney cancer, neuroendocrine tumors and liver cancer and is further utilised for the treatment of aneurysyms, uterine fibroids and various such diseases and are commonly being known as TAE or arterial embolization and is performing vital role in strengthening the growth of the global embolotherapy market at rapid pace.

Insight by Indication

Based on indication, the global embolotherapy market is segmented into cancer, neurological diseases, peripheral vascular diseases, urological & nephrological disorders, and gastrointestinal disorders, wherein cancer category held the largest share in the market in 2020, owing to the rising prevalence of cancer, especially kidney and liver cancers.

Cancer category is further segmented into the liver, kidney, and others.

Neurological diseases are further segmented into cerebral aneurysm, and arteriovenous malformation and fistulas.

Insight by End User

Based on end user, the global embolotherapy market is segmented into ambulatory surgical centers (ASCs), hospitals and clinics, and others. Amongst these segments, hospitals and clinics are dominating in terms of revenue throughout the estimated period owing to extensive accessibility of reimbursements policies being implemented by hospitals and clinics and excessive adoption of these devices in small clinics, big hospitals and critical care units.

Global Embolotherapy Market Report Coverage

Industry Dynamics

Growth Drivers

Increasing target population of patient along with extensive preference of patients for minimally invasive techniques are the key factors that are driving the growth of global embolotherapy market. Several patients across the globe require embolotherapy processes for treating several diseases for instance liver cancer tumors, kidney cancer, hepatocellular, renal cell carcinoma, aneurysms and varicose veins. Moreover, embolotherapy has wider usage in clinical settings such as in the treatment of non-trauma related vascular disorders and treatment of inflammation that is significantly contributing towards the growth of the global embolotherapy market.

Furthermore, improving healthcare infrastructure along with increasing expenditure on healthcare domain are other factors that are driving the growth of global embolotherapy market. Additionally, increasing burden of target diseases, grants and funds for the growth of novel offerings are other factors pertaining towards the growth of global embolotherapy market. Furthermore, excessive demand for minimally invasive surgery procedures, favourable reimbursement scenario and new product launches are further anticipated to strengthen the growth of global embolotherapy market.

Furthermore, increasing adoption of minimally invasive surgical processes such as neurological, vascular and urological and existence of consolidated market structure amongst healthcare providers along with their increasing purchasing power are the key factors that are pertaining towards the growth of global embolotherapy market.

Restraints

Challenges and risks related with embolization is the key factor that is anticipated to hamper the growth of the global embolotherapy market.

Geography Insight

North America has accounted for the largest share in embolotherapy market, globally and is predicted to grow significantly during the forecast period, owing to the increasing emphasis in the region towards development of advanced embolic agents, extensive pervasiveness of incidents that necessitates adoption of embolization processes. Moreover, established healthcare system in this region is the key factor that is further anticipated to drive the growth of embolotherapy market in this region.

Moreover, embolotherapy market in Asia-Pacific is anticipated to witness fastest growth during the forecast period owing to the increasing number of patient’s population, increasing emphasis by the government authorities in the region towards healthcare expenditure and rapid incidences of cancer among individuals. Additionally, presence of key players emphasizing upon technological advancements are the key factors that are pertaining towards the growth of embolotherapy market in this region.

Competitive Insight

The eminent key players in the global embolotherapy market are undertaking considerable investment decisions and launching new products in order gain competitive advantage. Moreover, entering into partnership agreements and performing mergers & acquisitions are the key development strategies being implemented by the crucial players in the global embolotherapy market.

Some of the players having prominent presence in the global embolotherapy market include Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from the industry experts. The key profiles approached within the industry include CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads, and Others. Also, end-user surveys comprising of consumers are also conducted to understand consumer behavior.

The Embolotherapy Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2021–2027.

Segments Covered in the Report

• By Product 
  • Embolic Agents
    • Microspheres
    • Embolic Coils
    • Liquid Embolic Agents
    • Embolic Plug Systems
    • Detachable Balloons
  • Support Devices
    • Microcatheters
    • Guidewires
• By Procedure
  • Transcatheter Arterial Embolization (TAE)
  • Transarterial Chemoembolization (TACE)
  • Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
• By Indication 
  • Cancer
    • Liver
    • Kidney
    • Others
  • Neurological Diseases
    • Cerebral Aneurysm
    • Arteriovenous Malformation And Fistulas
  • Peripheral Vascular Diseases
  • Urological and Nephrological Disorders
  • Gastrointestinal Disorders
• By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research

1. Research Overview

        1.1. The Report Offers
        1.2. Market Coverage
                1.2.1. By Product
                1.2.2. By Procedure
                1.2.3. By Indication
                1.2.4. By End User
                1.2.5. By Region
        1.3. Research Phases
        1.4. Limitations
        1.5. Market Size Estimations and Forecast
                1.5.1. Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2. Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3. Study Period & Data Reporting Unit

2. Executive Summary

3. Market Definition

        3.1. By Product
                3.1.1. Embolic Agents
                        3.1.1.1. Microspheres
                        3.1.1.2. Embolic Coils
                        3.1.1.3. Liquid Embolic Agents
                        3.1.1.4. Embolic Plug Systems
                        3.1.1.5. Detachable Balloons
                3.1.2. Support Devices
                        3.1.2.1. Microcatheters
                        3.1.2.2. Guidewires
        3.2. By Procedure
                3.2.1. Transcatheter Arterial Embolization (TAE)
                3.2.2. Transarterial Chemoembolization (TACE)
                3.2.3. Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
        3.3. By Indication
                3.3.1. Cancer
                        3.3.1.1. Liver
                        3.3.1.2. Kidney
                        3.3.1.3. Others
                3.3.2. Neurological Diseases
                        3.3.2.1. Cerebral Aneurysm
                        3.3.2.2. Arteriovenous Malformation and Fistulas
                3.3.3. Peripheral Vascular Diseases
                3.3.4. Urological and Nephrological Disorders
                3.3.5. Gastrointestinal Disorders
        3.4. By End User
                3.4.1. Hospitals and Clinics
                3.4.2. Ambulatory Surgical Centers (ASCs)
                3.4.3. Others

4. Industry Overview

        4.1. Industry Dynamics
                4.1.1. Market Growth Drivers
                4.1.2. Market Growth Restraints
                4.1.3. Key Market Trends
                4.1.4. Major Opportunities
        4.2. Industry Ecosystem
                4.2.1. Porter’s Five Forces Analysis
                4.2.2. Recent Development Analysis
                4.2.3. Value Chain Analysis
        4.3. Competitive Insight
                4.3.1. Competitive Position of Industry Players
                4.3.2. Market Attractive Analysis
                4.3.3. Market Share Analysis

5. Global Market Estimate and Forecast

        5.1. By Product
        5.2. By Procedure
        5.3. By Indication
        5.4. By End User
        5.5. By Region

6. North America Market Estimate and Forecast

        6.1. By Product
        6.2. By Procedure
        6.3. By Indication
        6.4. By End User
        6.5. By Country
                6.5.1. U.S. Market Estimate and Forecast
                        6.5.1.1. By Product
                        6.5.1.2. By Procedure
                        6.5.1.3. By Indication
                        6.5.1.4. By End User
                6.5.2. Canada Market Estimate and Forecast
                        6.5.2.1. By Product
                        6.5.2.2. By Procedure
                        6.5.2.3. By Indication
                        6.5.2.4. By End User
                6.5.3. Mexico Market Estimate and Forecast
                        6.5.3.1. By Product
                        6.5.3.2. By Procedure
                        6.5.3.3. By Indication
                        6.5.3.4. By End User

7. Europe Market Estimate and Forecast

        7.1. By Product
        7.2. By Procedure
        7.3. By Indication
        7.4. By End User
        7.5. By Country
                7.5.1. Germany Market Estimate and Forecast
                        7.5.1.1. By Product
                        7.5.1.2. By Procedure
                        7.5.1.3. By Indication
                        7.5.1.4. By End User
        7.5.2. France Market Estimate and Forecast
                        7.5.2.1. By Product
                        7.5.2.2. By Procedure
                        7.5.2.3. By Indication
                        7.5.2.4. By End User
        7.5.3. U.K. Market Estimate and Forecast
                        7.5.3.1. By Product
                        7.5.3.2. By Procedure
                        7.5.3.3. By Indication
                        7.5.3.4. By End User
        7.5.4. Italy Market Estimate and Forecast
                        7.5.4.1. By Product
                        7.5.4.2. By Procedure
                        7.5.4.3. By Indication
                        7.5.4.4. By End User
        7.5.5. Spain Market Estimate and Forecast
                        7.5.5.1. By Product
                        7.5.5.2. By Procedure
                        7.5.5.3. By Indication
                        7.5.5.4. By End User
        7.5.6. Rest of Europe Market Estimate and Forecast
                        7.5.6.1. By Product
                        7.5.6.2. By Procedure
                        7.5.6.3. By Indication
                        7.5.6.4. By End User

8. Asia-Pacific Market Estimate and Forecast

        8.1. By Product
        8.2. By Procedure
        8.3. By Indication
        8.4. By End User
        8.5. By Country 
                8.5.1. China Market Estimate and Forecast
                        8.5.1.1. By Product
                        8.5.1.2. By Procedure
                        8.5.1.3. By Indication
                        8.5.1.4. By End User
                8.5.2. Japan Market Estimate and Forecast
                        8.5.2.1. By Product
                        8.5.2.2. By Procedure
                        8.5.2.3. By Indication
                        8.5.2.4. By End User
                8.5.3. India Market Estimate and Forecast
                        8.5.3.1. By Product
                        8.5.3.2. By Procedure
                        8.5.3.3. By Indication
                        8.5.3.4. By End User
                8.5.4. South Korea Market Estimate and Forecast
                        8.5.4.1. By Product
                        8.5.4.2. By Procedure
                        8.5.4.3. By Indication
                        8.5.4.4. By End User
                8.5.5. Singapore Market Estimate and Forecast
                        8.5.5.1. By Product
                        8.5.5.2. By Procedure
                        8.5.5.3. By Indication
                        8.5.5.4. By End User
                8.5.6. Rest of Asia-Pacific Market Estimate and Forecast
                        8.5.6.1. By Product
                        8.5.6.2. By Procedure
                        8.5.6.3. By Indication
                        8.5.6.4. By End User

9. Rest of the World (RoW) Market Estimate and Forecast

        9.1. By Product
        9.2. By Procedure
        9.3. By Indication
        9.4. By End User
        9.5. By Country
                9.5.1. Brazil Market Estimate and Forecast
                        9.5.1.1. By Product
                        9.5.1.2. By Procedure
                        9.5.1.3. By Indication
                        9.5.1.4. By End User
                9.5.2. Saudi Arabia Market Estimate and Forecast
                        9.5.2.1. By Product
                        9.5.2.2. By Procedure
                        9.5.2.3. By Indication
                        9.5.2.4. By End User
                9.5.3. South Africa Market Estimate and Forecast
                        9.5.3.1. By Product
                        9.5.3.2. By Procedure
                        9.5.3.3. By Indication
                        9.5.3.4. By End User
                9.5.4. Other Countries Market Estimate and Forecast
                        9.5.4.1. By Product
                        9.5.4.2. By Procedure
                        9.5.4.3. By Indication
                        9.5.4.4. By End User

10. Company Profiles

        10.1. Merit Medical Systems
                10.1.1. Snapshot
                10.1.2. Overview
                10.1.3. Offerings
                10.1.4. Financial Insight
                10.1.5. Recent Developments
        10.2. Acandis GmbH
                10.2.1. Snapshot
                10.2.2. Overview
                10.2.3. Offerings
                10.2.4. Financial Insight
                10.2.5. Recent Developments
        10.3. Medtronic plc
                10.3.1. Snapshot
                10.3.2. Overview
                10.3.3. Offerings
                10.3.4. Financial Insight
                10.3.5. Recent Developments
        10.4. Abbott Laboratories
                10.4.1. Snapshot
                10.4.2. Overview
                10.4.3. Offerings
                10.4.4. Financial Insight
                10.4.5. Recent Developments
        10.5. Boston Scientific Corporation
                10.5.1. Snapshot
                10.5.2. Overview
                10.5.3. Offerings
                10.5.4. Financial Insight
                10.5.5. Recent Developments
        10.6. Cook Medical
                10.6.1. Snapshot
                10.6.2. Overview
                10.6.3. Offerings
                10.6.4. Financial Insight
                10.6.5. Recent Developments
        10.7. Terumo Corporation
                10.7.1. Snapshot
                10.7.2. Overview
                10.7.3. Offerings
                10.7.4. Financial Insight
                10.7.5. Recent Developments
        10.8. Stryker Corporation
                10.8.1. Snapshot
                10.8.2. Overview
                10.8.3. Offerings
                10.8.4. Financial Insight
                10.8.5. Recent Developments
        10.9. Johnson & Johnson
                10.9.1. Snapshot
                10.9.2. Overview
                10.9.3. Offerings
                10.9.4. Financial Insight
                10.9.5. Recent Developments
        10.10. BALT Extrusion
                10.10.1. Snapshot
                10.10.2. Overview
                10.10.3. Offerings
                10.10.4. Financial Insight
                10.10.5. Recent Developments
        10.11. Sirtex Medical Limited
                10.11.1. Snapshot
                10.11.2. Overview
                10.11.3. Offerings
                10.11.4. Financial Insight
                10.11.5. Recent Developments
        10.12. Kaneka Corporation
                10.12.1. Snapshot
                10.12.2. Overview
                10.12.3. Offerings
                10.12.4. Financial Insight
                10.12.5. Recent Developments
        10.13. Meril Life Sciences Pvt. Ltd.
                10.13.1. Snapshot
                10.13.2. Overview
                10.13.3. Offerings
                10.13.4. Financial Insight
                10.13.5. Recent Developments
        10.14. Penumbra, Inc.
                10.14.1. Snapshot
                10.14.2. Overview
                10.14.3. Offerings
                10.14.4. Financial Insight
                10.14.5. Recent Developments
        10.15. BTG Plc
                10.15.1. Snapshot
                10.15.2. Overview
                10.15.3. Offerings
                10.15.4. Financial Insight
                10.15.5. Recent Developments

11. Appendix

        11.1. Exchange Rates
        11.2. Abbreviations

Note: Financial insight and recent developments of different companies are subject to availability of information in secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 5 Global Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 6 Global Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 7 Global Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 8 Global Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 9 Global Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 10 Global Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 11 Global Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 12 Global Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 13 Global Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 14 Global Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 15 Global Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 16 Global Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 17 Global Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 18 Global Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 19 Global Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 20 Global Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 21 Global Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 22 Global Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 23 Global Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 24 Global Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 25 Global Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 26 Global Embolotherapy Market Size, by Region, 2015–2020 (USD Million)
Table 27 Global Embolotherapy Market Size, by Region, 2021–2027 (USD Million)
Table 28 North America Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 29 North America Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 30 North America Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 31 North America Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 32 North America Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 33 North America Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 34 North America Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 35 North America Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 36 North America Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 37 North America Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 38 North America Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 39 North America Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 40 North America Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 41 North America Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 42 North America Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 43 North America Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 44 North America Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 45 North America Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 46 North America Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 47 North America Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 48 North America Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 49 North America Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 50 North America Embolotherapy Market Size, by Country, 2015–2020 (USD Million)
Table 51 North America Embolotherapy Market Size, by Country, 2021–2027 (USD Million)
Table 52 U.S. Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 53 U.S. Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 54 U.S. Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 55 U.S. Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 56 U.S. Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 57 U.S. Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 58 U.S. Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 59 U.S. Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 60 U.S. Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 61 U.S. Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 62 U.S. Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 63 U.S. Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 64 U.S. Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 65 U.S. Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 66 U.S. Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 67 U.S. Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 68 U.S. Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 69 U.S. Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 70 U.S. Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 71 U.S. Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 72 U.S. Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 73 U.S. Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 74 Canada Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 75 Canada Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 76 Canada Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 77 Canada Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 78 Canada Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 79 Canada Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 80 Canada Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 81 Canada Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 82 Canada Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 83 Canada Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 84 Canada Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 85 Canada Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 86 Canada Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 87 Canada Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 88 Canada Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 89 Canada Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 90 Canada Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 91 Canada Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 92 Canada Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 93 Canada Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 94 Canada Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 95 Canada Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 96 Mexico Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 97 Mexico Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 98 Mexico Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 99 Mexico Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 100 Mexico Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 101 Mexico Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 102 Mexico Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 103 Mexico Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 104 Mexico Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 105 Mexico Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 106 Mexico Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 107 Mexico Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 108 Mexico Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 109 Mexico Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 110 Mexico Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 111 Mexico Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 112 Mexico Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 113 Mexico Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 114 Mexico Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 115 Mexico Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 116 Mexico Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 117 Mexico Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 118 Europe Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 119 Europe Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 120 Europe Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 121 Europe Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 122 Europe Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 123 Europe Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 124 Europe Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 125 Europe Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 126 Europe Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 127 Europe Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 128 Europe Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 129 Europe Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 130 Europe Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 131 Europe Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 132 Europe Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 133 Europe Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 134 Europe Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 135 Europe Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 136 Europe Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 137 Europe Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 138 Europe Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 139 Europe Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 140 Europe Embolotherapy Market Size, by Country, 2015–2020 (USD Million)
Table 141 Europe Embolotherapy Market Size, by Country, 2021–2027 (USD Million)
Table 142 U.K. Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 143 U.K. Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 144 U.K. Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 145 U.K. Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 146 U.K. Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 147 U.K. Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 148 U.K. Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 149 U.K. Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 150 U.K. Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 151 U.K. Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 152 U.K. Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 153 U.K. Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 154 U.K. Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 155 U.K. Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 156 U.K. Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 157 U.K. Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 158 U.K. Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 159 U.K. Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 160 U.K. Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 161 U.K. Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 162 U.K. Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 163 U.K. Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 164 Germany Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 165 Germany Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 166 Germany Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 167 Germany Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 168 Germany Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 169 Germany Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 170 Germany Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 171 Germany Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 172 Germany Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 173 Germany Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 174 Germany Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 175 Germany Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 176 Germany Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 177 Germany Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 178 Germany Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 179 Germany Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 180 Germany Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 181 Germany Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 182 Germany Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 183 Germany Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 184 Germany Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 185 Germany Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 186 France Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 187 France Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 188 France Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 189 France Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 190 France Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 191 France Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 192 France Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 193 France Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 194 France Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 195 France Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 196 France Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 197 France Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 198 France Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 199 France Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 200 France Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 201 France Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 202 France Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 203 France Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 204 France Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 205 France Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 206 France Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 207 France Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 208 Italy Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 209 Italy Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 210 Italy Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 211 Italy Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 212 Italy Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 213 Italy Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 214 Italy Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 215 Italy Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 216 Italy Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 217 Italy Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 218 Italy Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 219 Italy Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 220 Italy Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 221 Italy Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 222 Italy Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 223 Italy Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 224 Italy Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 225 Italy Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 226 Italy Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 227 Italy Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 228 Italy Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 229 Italy Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 230 Spain Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 231 Spain Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 232 Spain Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 233 Spain Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 234 Spain Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 235 Spain Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 236 Spain Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 237 Spain Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 238 Spain Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 239 Spain Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 240 Spain Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 241 Spain Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 242 Spain Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 243 Spain Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 244 Spain Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 245 Spain Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 246 Spain Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 247 Spain Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 248 Spain Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 249 Spain Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 250 Spain Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 251 Spain Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 252 Rest of Europe Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 253 Rest of Europe Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 254 Rest of Europe Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 255 Rest of Europe Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 256 Rest of Europe Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 257 Rest of Europe Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 258 Rest of Europe Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 259 Rest of Europe Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 260 Rest of Europe Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 261 Rest of Europe Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 262 Rest of Europe Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 263 Rest of Europe Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 264 Rest of Europe Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 265 Rest of Europe Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 266 Rest of Europe Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 267 Rest of Europe Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 268 Rest of Europe Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 269 Rest of Europe Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 270 Rest of Europe Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 271 Rest of Europe Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 272 Rest of Europe Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 273 Rest of Europe Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 274 Asia-Pacific Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 275 Asia-Pacific Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 276 Asia-Pacific Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 277 Asia-Pacific Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 278 Asia-Pacific Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 279 Asia-Pacific Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 280 Asia-Pacific Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 281 Asia-Pacific Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 282 Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 283 Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 284 Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 285 Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 286 Asia-Pacific Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 287 Asia-Pacific Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 288 Asia-Pacific Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 289 Asia-Pacific Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 290 Asia-Pacific Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 291 Asia-Pacific Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 292 Asia-Pacific Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 293 Asia-Pacific Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 294 Asia-Pacific Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 295 Asia-Pacific Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 296 Asia-Pacific Embolotherapy Market Size, by Country, 2015–2020 (USD Million)
Table 297 Asia-Pacific Embolotherapy Market Size, by Country, 2021–2027 (USD Million)
Table 298 China Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 299 China Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 300 China Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 301 China Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 302 China Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 303 China Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 304 China Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 305 China Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 306 China Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 307 China Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 308 China Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 309 China Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 310 China Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 311 China Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 312 China Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 313 China Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 314 China Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 315 China Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 316 China Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 317 China Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 318 China Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 319 China Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 320 Japan Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 321 Japan Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 322 Japan Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 323 Japan Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 324 Japan Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 325 Japan Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 326 Japan Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 327 Japan Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 328 Japan Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 329 Japan Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 330 Japan Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 331 Japan Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 332 Japan Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 333 Japan Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 334 Japan Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 335 Japan Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 336 Japan Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 337 Japan Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 338 Japan Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 339 Japan Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 340 Japan Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 341 Japan Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 342 India Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 343 India Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 344 India Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 345 India Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 346 India Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 347 India Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 348 India Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 349 India Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 350 India Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 351 India Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 352 India Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 353 India Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 354 India Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 355 India Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 356 India Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 357 India Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 358 India Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 359 India Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 360 India Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 361 India Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 362 India Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 363 India Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 364 South Korea Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 365 South Korea Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 366 South Korea Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 367 South Korea Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 368 South Korea Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 369 South Korea Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 370 South Korea Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 371 South Korea Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 372 South Korea Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 373 South Korea Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 374 South Korea Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 375 South Korea Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 376 South Korea Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 377 South Korea Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 378 South Korea Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 379 South Korea Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 380 South Korea Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 381 South Korea Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 382 South Korea Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 383 South Korea Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 384 South Korea Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 385 South Korea Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 386 Singapore Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 387 Singapore Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 388 Singapore Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 389 Singapore Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 390 Singapore Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 391 Singapore Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 392 Singapore Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 393 Singapore Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 394 Singapore Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 395 Singapore Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 396 Singapore Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 397 Singapore Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 398 Singapore Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 399 Singapore Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 400 Singapore Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 401 Singapore Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 402 Singapore Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 403 Singapore Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 404 Singapore Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 405 Singapore Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 406 Singapore Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 407 Singapore Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 408 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 409 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 410 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 411 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 412 Rest of Asia-Pacific Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 413 Rest of Asia-Pacific Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 414 Rest of Asia-Pacific Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 415 Rest of Asia-Pacific Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 416 Rest of Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 417 Rest of Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 418 Rest of Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 419 Rest of Asia-Pacific Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 420 Rest of Asia-Pacific Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 421 Rest of Asia-Pacific Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 422 Rest of Asia-Pacific Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 423 Rest of Asia-Pacific Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 424 Rest of Asia-Pacific Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 425 Rest of Asia-Pacific Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 426 Rest of Asia-Pacific Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 427 Rest of Asia-Pacific Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 428 Rest of Asia-Pacific Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 429 Rest of Asia-Pacific Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 430 RoW Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 431 RoW Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 432 RoW Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 433 RoW Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 434 RoW Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 435 RoW Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 436 RoW Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 437 RoW Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 438 RoW Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 439 RoW Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 440 RoW Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 441 RoW Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 442 RoW Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 443 RoW Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 444 RoW Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 445 RoW Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 446 RoW Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 447 RoW Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 448 RoW Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 449 RoW Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 450 RoW Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 451 RoW Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 452 RoW Embolotherapy Market Size, by Country, 2015–2020 (USD Million)
Table 453 RoW Embolotherapy Market Size, by Country, 2021–2027 (USD Million)
Table 454 Brazil Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 455 Brazil Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 456 Brazil Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 457 Brazil Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 458 Brazil Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 459 Brazil Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 460 Brazil Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 461 Brazil Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 462 Brazil Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 463 Brazil Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 464 Brazil Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 465 Brazil Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 466 Brazil Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 467 Brazil Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 468 Brazil Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 469 Brazil Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 470 Brazil Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 471 Brazil Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 472 Brazil Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 473 Brazil Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 474 Brazil Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 475 Brazil Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 476 Saudi Arabia Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 477 Saudi Arabia Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 478 Saudi Arabia Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 479 Saudi Arabia Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 480 Saudi Arabia Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 481 Saudi Arabia Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 482 Saudi Arabia Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 483 Saudi Arabia Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 484 Saudi Arabia Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 485 Saudi Arabia Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 486 Saudi Arabia Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 487 Saudi Arabia Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 488 Saudi Arabia Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 489 Saudi Arabia Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 490 Saudi Arabia Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 491 Saudi Arabia Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 492 Saudi Arabia Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 493 Saudi Arabia Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 494 Saudi Arabia Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 495 Saudi Arabia Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 496 Saudi Arabia Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 497 Saudi Arabia Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 498 South Africa Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 499 South Africa Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 500 South Africa Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 501 South Africa Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 502 South Africa Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 503 South Africa Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 504 South Africa Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 505 South Africa Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 506 South Africa Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 507 South Africa Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 508 South Africa Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 509 South Africa Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 510 South Africa Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 511 South Africa Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 512 South Africa Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 513 South Africa Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 514 South Africa Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 515 South Africa Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 516 South Africa Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 517 South Africa Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 518 South Africa Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 519 South Africa Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 520 Other Countries Embolotherapy Market Size, by Product, 2015–2020 (Unit)
Table 521 Other Countries Embolotherapy Market Size, by Product, 2021–2027 (Unit)
Table 522 Other Countries Embolotherapy Market Size, by Product, 2015–2020 (USD Million)
Table 523 Other Countries Embolotherapy Market Size, by Product, 2021–2027 (USD Million)
Table 524 Other Countries Embolic Agents Market Size, by Type, 2015–2020 (Unit)
Table 525 Other Countries Embolic Agents Market Size, by Type, 2021–2027 (Unit)
Table 526 Other Countries Embolic Agents Market Size, by Type, 2015–2020 (USD Million)
Table 527 Other Countries Embolic Agents Market Size, by Type, 2021–2027 (USD Million)
Table 528 Other Countries Embolotherapy Support Devices Market Size, by Type, 2015–2020 (Unit)
Table 529 Other Countries Embolotherapy Support Devices Market Size, by Type, 2021–2027 (Unit)
Table 530 Other Countries Embolotherapy Support Devices Market Size, by Type, 2015–2020 (USD Million)
Table 531 Other Countries Embolotherapy Support Devices Market Size, by Type, 2021–2027 (USD Million)
Table 532 Other Countries Embolotherapy Market Size, by Procedure, 2015–2020 (USD Million)
Table 533 Other Countries Embolotherapy Market Size, by Procedure, 2021–2027 (USD Million)
Table 534 Other Countries Embolotherapy Market Size, by Indication, 2015–2020 (USD Million)
Table 535 Other Countries Embolotherapy Market Size, by Indication, 2021–2027 (USD Million)
Table 536 Other Countries Embolotherapy Market Size For Cancer, by Type, 2015–2020 (USD Million)
Table 537 Other Countries Embolotherapy Market Size For Cancer, by Type, 2021–2027 (USD Million)
Table 538 Other Countries Embolotherapy Market Size For Neurological Diseases, by Type, 2015–2020 (USD Million)
Table 539 Other Countries Embolotherapy Market Size For Neurological Diseases, by Type, 2021–2027 (USD Million)
Table 540 Other Countries Embolotherapy Market Size, by End User, 2015–2020 (USD Million)
Table 541 Other Countries Embolotherapy Market Size, by End User, 2021–2027 (USD Million)
Table 542 Snapshot – Merit Medical Systems
Table 543 Snapshot – Acandis GmbH
Table 544 Snapshot – Medtronic plc
Table 545 Snapshot – Abbott Laboratories
Table 546 Snapshot – Boston Scientific Corporation
Table 547 Snapshot – Cook Medical
Table 548 Snapshot – Terumo Corporation
Table 549 Snapshot – Stryker Corporation
Table 550 Snapshot – Johnson & Johnson
Table 551 Snapshot – BALT Extrusion
Table 552 Snapshot – Sirtex Medical Limited
Table 553 Snapshot – Kaneka Corporation
Table 554 Snapshot – Meril Life Sciences Pvt. Ltd.
Table 555 Snapshot – Penumbra, Inc.
Table 556 Snapshot – BTG Plc

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Types for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Embolotherapy Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Embolotherapy Market Highlight
Figure 12 Global Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 13 Global Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 14 Global Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 15 Global Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 16 Global Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 17 Global Embolotherapy Market Size, by Region, 2015–2027 (USD Million)
Figure 18 North America Embolotherapy Market Highlight
Figure 19 North America Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 20 North America Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 21 North America Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 22 North America Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 23 North America Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 24 North America Embolotherapy Market Size, by Country, 2015–2027 (USD Million)
Figure 25 U.S. Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 26 U.S. Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 27 U.S. Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 28 U.S. Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 29 U.S. Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 30 Canada Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 31 Canada Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 32 Canada Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 33 Canada Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 34 Canada Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 35 Mexico Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 36 Mexico Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 37 Mexico Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 38 Mexico Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 39 Mexico Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 40 Europe Embolotherapy Market Highlight
Figure 41 Europe Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 42 Europe Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 43 Europe Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 44 Europe Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 45 Europe Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 46 Europe Embolotherapy Market Size, by Country, 2015–2027 (USD Million)
Figure 47 U.K. Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 48 U.K. Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 49 U.K. Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 50 U.K. Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 51 U.K. Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 52 Germany Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 53 Germany Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 54 Germany Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 55 Germany Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 56 Germany Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 57 France Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 58 France Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 59 France Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 60 France Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 61 France Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 62 Italy Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 63 Italy Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 64 Italy Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 65 Italy Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 66 Italy Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 67 Spain Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 68 Spain Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 69 Spain Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 70 Spain Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 71 Spain Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 72 Rest of Europe Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 73 Rest of Europe Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 74 Rest of Europe Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 75 Rest of Europe Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 76 Rest of Europe Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 77 Asia-Pacific Embolotherapy Market Highlight
Figure 78 Asia-Pacific Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 79 Asia-Pacific Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 80 Asia-Pacific Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 81 Asia-Pacific Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 82 Asia-Pacific Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 83 Asia-Pacific Embolotherapy Market Size, by Country, 2015–2027 (USD Million)
Figure 84 China Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 85 China Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 86 China Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 87 China Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 88 China Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 89 Japan Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 90 Japan Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 91 Japan Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 92 Japan Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 93 Japan Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 94 India Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 95 India Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 96 India Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 97 India Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 98 India Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 99 South Korea Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 100 South Korea Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 101 South Korea Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 102 South Korea Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 103 South Korea Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 104 Singapore Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 105 Singapore Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 106 Singapore Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 107 Singapore Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 108 Singapore Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 109 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 110 Rest of Asia-Pacific Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 111 Rest of Asia-Pacific Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 112 Rest of Asia-Pacific Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 113 Rest of Asia-Pacific Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 114 RoW Embolotherapy Market Highlight
Figure 115 RoW Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 116 RoW Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 117 RoW Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 118 RoW Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 119 RoW Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 120 RoW Embolotherapy Market Size, by Country, 2015–2027 (USD Million)
Figure 121 Brazil Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 122 Brazil Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 123 Brazil Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 124 Brazil Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 125 Brazil Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 126 South Africa Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 127 South Africa Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 128 South Africa Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 129 South Africa Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 130 South Africa Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 131 Saudi Arabia Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 132 Saudi Arabia Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 133 Saudi Arabia Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 134 Saudi Arabia Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 135 Saudi Arabia Embolotherapy Market Size, by End User, 2015–2027 (USD Million)
Figure 136 Other Countries Embolotherapy Market Size, by Product, 2015–2027 (Unit)
Figure 137 Other Countries Embolotherapy Market Size, by Product, 2015–2027 (USD Million)
Figure 138 Other Countries Embolotherapy Market Size, by Procedure, 2015–2027 (USD Million)
Figure 139 Other Countries Embolotherapy Market Size, by Indication, 2015–2027 (USD Million)
Figure 140 Other Countries Embolotherapy Market Size, by End User, 2015–2027 (USD Million)